Details

Autor(en) / Beteiligte

• Bieber, Stéphanie
• Kraechan, Angelina
• Hellmuth, Johannes C.
• Muenchhoff, Maximilian
• Scherer, Clemens
• Schroeder, Ines
• Irlbeck, Michael
• Kaeaeb, Stefan
• Massberg, Steffen
• Hausleiter, Joerg
• Grabmaier, Ulrich
• Orban, Mathias
• Weckbach, Ludwig T.

Titel

Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury

Ist Teil von

• Infection, 2021-06, Vol.49 (3), p.491-500

Ort / Verlag

Berlin/Heidelberg: Springer Berlin Heidelberg

Erscheinungsjahr

2021

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Purpose SARS-COV-2 infection can develop into a multi-organ disease. Although pathophysiological mechanisms of COVID-19-associated myocardial injury have been studied throughout the pandemic course in 2019, its morphological characterisation is still unclear. With this study, we aimed to characterise echocardiographic patterns of ventricular function in patients with COVID-19-associated myocardial injury. Methods We prospectively assessed 32 patients hospitalised with COVID-19 and presence or absence of elevated high sensitive troponin T (hsTNT+ vs. hsTNT-) by comprehensive three-dimensional (3D) and strain echocardiography. Results A minority (34.3%) of patients had normal ventricular function, whereas 65.7% had left and/or right ventricular dysfunction defined by impaired left and/or right ventricular ejection fraction and strain measurements. Concomitant biventricular dysfunction was common in hsTNT+ patients. We observed impaired left ventricular (LV) global longitudinal strain (GLS) in patients with myocardial injury (-13.9% vs. -17.7% for hsTNT+ vs. hsTNT-, p  = 0.005) but preserved LV ejection fraction (52% vs. 59%, p  = 0.074). Further, in these patients, right ventricular (RV) systolic function was impaired with lower RV ejection fraction (40% vs. 49%, p  = 0.001) and reduced RV free wall strain (-18.5% vs. -28.3%, p  = 0.003). Myocardial dysfunction partially recovered in hsTNT + patients after 52 days of follow-up. In particular, LV-GLS and RV-FWS significantly improved from baseline to follow-up (LV-GLS: -13.9% to -16.5%, p  = 0.013; RV-FWS: -18.5% to -22.3%, p  = 0.037). Conclusion In patients with COVID-19-associated myocardial injury, comprehensive 3D and strain echocardiography revealed LV dysfunction by GLS and RV dysfunction, which partially resolved at 2-month follow-up. Trial registration COVID-19 Registry of the LMU University Hospital Munich (CORKUM), WHO trial ID DRKS00021225.